Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?

被引：0
|
作者：
Felicetto Ferrara
机构：
[1] Cardarelli Hospital,Division of Hematology
来源：
Blood Cancer Journal | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Comparison of DNA hypomethylating agents and low dose cytarabine in elderly acute myeloid leukemia patients: A meta-analysis.
    Vincelette, Nicole
    Yun, Seongseok
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia
    Weng, Guangyang
    Zhang, Yu
    Yu, Guopan
    Luo, Tingyue
    Yu, Sijian
    Xu, Na
    Sun, Zhiqiang
    Lin, Dongjun
    Deng, Lan
    Liang, Xinquan
    Xiao, Jie
    Zhang, Hongyu
    Guo, Ziwen
    Shao, Ruoyang
    Du, Xin
    Jin, Hua
    Liu, Qifa
    [J]. JOURNAL OF INTERNAL MEDICINE, 2023, 293 (03) : 329 - 339
  • [33] Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy
    de Camargo Magalhaes, Eduardo Sabino
    Hubner, Stefan Edward
    Brown, Brandon Douglas
    Qiu, Yihua
    Kornblau, Steven Mitchell
    [J]. LEUKEMIA, 2024, 38 (05) : 1046 - 1056
  • [34] Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy
    Eduardo Sabino de Camargo Magalhães
    Stefan Edward Hubner
    Brandon Douglas Brown
    Yihua Qiu
    Steven Mitchell Kornblau
    [J]. Leukemia, 2024, 38 : 1046 - 1056
  • [35] Association of Genetic Characteristics with Response to Venetoclax Plus Hypomethylating Agents in Relapsed and Refractory Acute Myeloid Leukemia
    Weng, Guangyang
    Zhang, Yu
    Yu, Guopan
    Xu, Na
    Sun, Zhiqiang
    Lin, Dongjun
    Liang, Xinquan
    Deng, Lan
    Xiao, Jie
    Zhang, Hongyu
    Guo, Ziwen
    Jin, Hua
    Du, Xin
    Liu, Qifa
    [J]. BLOOD, 2022, 140 : 2025 - 2026
  • [36] Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia (AML) - Real-World Data from Two German Academic Centers
    Schmalbrock, Laura K.
    Braitsch, Krischan
    Jung, Paul
    Bumeder, Irmgard
    Kiewe, Philipp
    Westermann, Joerg
    Bullinger, Lars
    Keller, Ulrich
    Bassermann, Florian
    Kroenke, Jan
    Rieger, Kathrin
    Goetze, Katharina S.
    [J]. BLOOD, 2021, 138
  • [37] Venetoclax Combined with Azacitidine or low-dose Cytarabine for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplant
    Smith, Katy
    Fathoala, Dina
    Anthias, Chloe
    Easdale, Sandra
    Ethell, Mark
    Potter, Mike
    Mir, Farheen
    Taussig, David
    Nicholson, Emma
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 188 - 189
  • [38] Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study
    Li, Yan-Yan
    Ge, Shuai-Shuai
    Huang, Yuan-Hong
    Xu, Ming-Zhu
    Wan, Chao-Ling
    Tan, Kai-Wen
    Tao, Tao
    Zhou, Hai-Xia
    Xue, Sheng-Li
    Dai, Hai-Ping
    [J]. BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [39] Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study
    Yan-Yan Li
    Shuai-Shuai Ge
    Yuan-Hong Huang
    Ming-Zhu Xu
    Chao-Ling Wan
    Kai-Wen Tan
    Tao Tao
    Hai-Xia Zhou
    Sheng-Li Xue
    Hai-Ping Dai
    [J]. Blood Cancer Journal, 14
  • [40] Venetoclax plus hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia Two case reports
    Wang, Hongxia
    Bai, Junjun
    Pei, Zhixin
    Zhang, Bei
    Wang, Junjie
    Lian, Xingli
    Song, Qinglin
    [J]. MEDICINE, 2020, 99 (47) : E23265
12345